Congenital NOS2 deficiency protects mice from LPS-induced hyporesponsiveness to inhaled nitric oxide

Anesthesiology

Volumn 91, Issue 6, 1999, Pages 1744-1753

  Weimann, Jörg ^b   Bloch, Kenneth D ^b   Takata, Masao ^b   Steudel, Wolfgang ^b   Zapol, Warren M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Gene deletion; Lipopolysaccharide; Mouse; Pulmonary circulation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ARGININE DERIVATIVE; ENDOTOXIN; GLUCOCORTICOID; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME DEFICIENCY; LUNG ARTERY PRESSURE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SEPSIS; VASODILATATION;

EID: 0032759253     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199912000-00028     Document Type: Article

References (33)

1. Bigatello LM, Hurford WE, Kacmarek RM, Roberts JD Jr, Zapol WM: Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. ANESTHESIOLOGY 1994; 80:761-70
2. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis KJ, Hyers TM, Papadakos P: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Crit Care Med 1998; 26:15-23
3. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
4. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM: Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83:2038-47
5. Fratacci MD, Frostell CG, Chen TY, Wain JC Jr, Robinson DR, Zapol WM: Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. ANESTHESIOLOGY 1991; 75:990-9
6. Shah NS, Nakayama DK, Jacob TD, Nishio I, Imai T, Billiar TR, Exler R, Yousem SA, Motoyama EK, Peitzman AB: Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome. Arch Surg 1994; 129:158-64
7. Ogura H, Offner PJ, Saitoh D, Jordan BS, Johnson AA, Pruitt BA Jr, Cioffi WG Jr: The pulmonary effect of nitric oxide synthase inhibition following endotoxemia in a swine model. Arch Surg 1994; 129:1233-9
8. Krafft P, Fridrich P, Fitzgerald RD, Koc D, Steltzer H: Effectiveness of nitric oxide inhalation in septic ARDS. Chest 1996; 109:486-93
9. Manktelow C, Bigatello LM, Hess D, Hurford WE: Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. ANESTHESIOLOGY 1997; 87:297-307
10. Lincoln TM, Cornwell TL: Intracellular cyclic GMP receptor proteins. FASEB J 1993; 7:328-38
11. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 1994; 298:249-58
12. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-42
13. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-8
14. Xia Y, Zweier JL: Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A 1997; 94:6954-8
15. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL: Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 1996; 93:6770-4
16. Fullerton DA, McIntyre RC Jr, Hahn AR, Agrafojo J, Koike K, Meng X, Banerjee A, Harken AH: Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Am J Physiol 1995; 268:L1029-35
17. Holzmann A, Bloch KD, Sanchez LS, Filippov G, Zapol WM: Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. Am J Physiol 1996; 271:L981-6
18. Holzmann A, Manktelow C, Bloch KD, Zapol WM: Inhibition of inducible nitric oxide (iNOS) prevents hyporesponsiveness to inhaled NO in lungs of lipopolysaccharide (LPS)-treated rats. ANESTHESIOLOGY 1999; 91:215-21
19. Southan GJ, Szabo C: Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996; 51:383-94
20. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-50
21. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, MacMicking JD, Nathan C, Kubes P: Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J 1997; 11:955-64
22. Weimann J, Hagenah JU, Motsch J: Reduction in nitrogen dioxide concentration by soda lime preparations during simulated nitric oxide inhalation. Br J Anaesth 1997; 79:641-4
23. Steudel W, Scherrer-Crosbie M, Bloch KD, Weimann J, Huang PL, Jones RC, Picard MH, Zapol WM: Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 1998; 101:2468-77
24. Tsuchida S, Hiraoka M, Sudo M, Kigoshi S, Muramatsu I: Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with endotoxin. Am J Physiol 1994; 267:H2305-10
25. Hinder F, Stubbe HD, van Aken H, Waurik R, Booke M, Meyer J: Role of nitric oxide in sepsis-associated pulmonary edema. Am J Resp Crit Care Med 1999; 159:252-7
26. Combes X, Mazmanian M, Gourlain H, Herve P: Effect of 48 hours of nitric oxide inhalation on pulmonary vasoreactivity in rats. Am J Respir Crit Care Med 1997; 156:473-7
27. Oka M, Ohnishi M, Takahashi H, Soma S, Hasunuma K, Sato K, Kira S: Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas. AmJ Physiol 1996; 271:L419-24
28. Roos CM, Frank DU, Xue C, Johns RA, Rich GF: Chronic inhaled nitric oxide: Effects on pulmonary vascular endothelial function and pathology in rats. J Appl Physiol 1996; 80:252-60
29. Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ: Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 1993; 19:443-9
30. Ungureanu-Longrois D, Balligand JL, Simmons WW, Okada I, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW: Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists. Circ Res 1995; 77:494-502
31. DeLeo FR, Renee J, McCormick S, Nakamura M, Apicella M, Weiss JP, Nauseef WM: Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest 1998; 101: 455-63
32. Sheridan BC, McIntyre RC, Agrafojo J, Meldrum DR, Meng X, Fullerton DA: Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation. Am J Physiol 1996; 271:L820-8
33. Kristof AS, Goldberg P, Laubach V, Hussain SNA: Role of inducible nitric oxide synthase in endotoxin-induced lung injury. Am J Respir Crit Care Med 1998; 158:1883-9